Release time：Aug 28, 2017
The "Recombinant Human Anti-TNF-α Monoclonal Antibody Injection Cooperative Development Agreement" was signed with Shanghai Junshi Bio-pharmaceutical Co., Ltd. to jointly conduct preclinical research of a recombinant human anti-TNF-α monoclonal antibody injection.
